A single-center experience with linear accelerator-based stereotactic radiotherapy for meningiomas: hypofractionation and radiosurgery
Authors:
Open Access
- 28 October 2022
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (1) , 103-109
Abstract
Purpose: Meningioma is a common type of benign tumor that can be managed in several ways, ranging from close observation, surgical resection, and various types of radiation. We present here results from a 10 year experience treating meningiomas with a hypofractionated approach. Materials and methods: To define the rate of tumor control and factors associated with the relief of symptoms and radiation-related complications after radiosurgery and hypofractionated radiosurgery for patients with imaging-defined intracranial meningiomas. We reviewed the charts of 48 patients treated with stereotactic radiosurgery (SRS) or hypofractionated stereotactic radiotherapy (SRT) from 2002 to 2018. A total of 37 (82%) patients had WHO Grade 1 disease, and 11 (22%) had Grade 2. Outcomes that were analyzed included local control rates and the rate and grade of any reported toxicity. Results: Only 36 patients with 38 lesions, who underwent the follow-up regime, were enrolled in the retrospective analysis. The follow-up mean was 40 months (12–120 months). 25/34 patients had surgery before the radiotherapy. Sixteen underwent SRS with a median dose of 13, 5, and 20 received hypofractionated SBRT with a median dose of 26.9 (22-45 Gy) in median six fractions (5–13 fractions). Local control at 2 and 5 years for all patients was 90 and 70%, respectively. No patient suffered from toxicity > 2 CTC. 21/36 patients showed stable disease, while 8/36 patients showed partial Remission. 7/36 developed recurrent meningioma (five in-field), only one patient with grade 1 meningioma, in a median of 22 months (13–48 months). Conclusion: SFRT was superior to SRS for local control in our analysis of Grade I meningiomas. This might be due to a tendency for higher EQD2 in the PTV with SFRT compared to SRS, which was reduced to avoid brain necrosis in large PTVs. Therefore, SFRT appears preferable for typical meningioma PTVs.Keywords
Funding Information
- Universitätsklinikum Magdeburg
This publication has 27 references indexed in Scilit:
- Stereotactic Radiosurgery of Intracranial MeningiomasNeurosurgery Clinics of North America, 2013
- Fractionated stereotactic radiosurgery for the treatment of meningiomasJournal of Cancer Research and Therapeutics, 2011
- Epidemiology and etiology of meningiomaJournal of Neuro-Oncology, 2010
- Radiosurgery for large-volume (> 10 cm3) benign meningiomasJournal of Neurosurgery, 2010
- Radiation Therapy Alone for Imaging-Defined MeningiomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- RADIOSURGERY AS DEFINITIVE MANAGEMENT OF INTRACRANIAL MENINGIOMASNeurosurgery, 2008
- Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: Long-term experience and prognostic factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Primarily Resected Meningiomas: Outcome and Prognostic Factors in 581 Mayo Clinic Patients, 1978 Through 1988Mayo Clinic Proceedings, 1998
- Factors Affecting Operative and Excess Long-term Mortality in 935 Patients with Intracranial MeningiomaNeurosurgery, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958